Teva expands European biosimilars push with AHZANTIVE launch for eye disease treatment
Teva said the launch strengthens its biosimilars strategy and expands access to biologic medicines across Europe
Teva said the launch strengthens its biosimilars strategy and expands access to biologic medicines across Europe
Targeting deadly drug-resistant acinetobacter infections
DST-backed researchers from Pune demonstrate targeted gene-silencing approach that significantly inhibits tumor growth with minimal toxicity
Veteran healthcare leader to oversee operations across Tamil Nadu and Kerala, driving growth and operational excellence
Highlights potential for at-home heart attack risk assessment, offering a new approach to reducing treatment delays
The facility integrates advanced scientific infrastructure and specialised workflows to support complex drug delivery systems, sterile injectables, and differentiated dosage forms
The ventilator features a high-performance turbine capable of delivering up to 240 L/min peak flow
A total of 300 transgender individuals were screened as part of the study, with 82 identified as high-risk due to symptoms of anxiety, depression, and self-harm or suicidal tendencies
Chennai based Bioneemtec India has received support from Technology Development Board for commercializing indigenous green chemistry technologies to produce critical pharmaceutical ingredients
Following the completion of the acquisition on June 3, Noctrix’s flagship product, Nidra will become part of ResMed’s broader sleep medicine portfolio
Subscribe To Our Newsletter & Stay Updated